跳至主要内容
临床试验/NCT03113721
NCT03113721Unknown不适用

Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the HBP Assay to Predict Development of Severe Sepsis in Patients With Suspected Infection Following ED Admission

Axis Shield Diagnostics Ltd5 个研究点 分布在 1 个国家目标入组 571 人开始时间: 2017年3月27日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
571
试验地点
5
主要终点
Measurement of plasma levels of HBP to evaluate patients with suspected infection for their risk of developing severe sepsis

研究概览

简要总结

The purpose of this prospective, non-interventional, multi-centre clinical study is to assess the clinical validity of the Heparin Binding Protein (HBP) assay for indicating the presence, or outcome, of severe sepsis (including septic shock), over 72 hours, in patients with suspected infection following emergency department admission.

详细描述

The primary objective of this study is to use HBP concentration to indicate the presence, or outcome, of severe sepsis (including septic shock) at admission and to predict the outcome of severe sepsis (including septic shock) over 72 hours, in patients with suspected infection following emergency department admission.

The secondary objectives of this study are to separately evaluate the performance of HBP concentration to a) indicate the presence of severe sepsis (including severe sepsis) at admission and b) to predict the outcome of severe sepsis (including septic shock) over 72 hours, in patients with suspected infection following emergency department admission.

Further exploratory objectives include evaluating the use of HBP measurement to indicate the outcome of severe sepsis (including septic shock) in patients with suspected infection 12-24 hours after emergency department admission, to compare the use of HBP to other markers of severe infection and to evaluate whether or not different cut-off values are required for the progression and outcome measures.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >18 years of age, suspected infection

排除标准

  • 未提供

结局指标

主要结局

Measurement of plasma levels of HBP to evaluate patients with suspected infection for their risk of developing severe sepsis

时间窗: 72 hours

The purpose of this measurement is to assess the clinical validity of plasma levels of HBP for indicating the presence, or outcome, of severe sepsis (including septic shock), over 72 hours, in patients with suspected infection following emergency department admission. The concentration of plasma HBP will be compared to the final clinical outcome of the patient to assess the ability of the HBP level to predict clinical progression.

次要结局

未报告次要终点

研究者

发起方
Axis Shield Diagnostics Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验